CCI vs EBS
Crown Castle (CCI) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CCI and EBS stock pages for the full models.
Not investment advice.